Optiver Holding B.V. Cassava Sciences Inc Call Options Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
132Shares Held
16.2MCall Options Held
1.05MPut Options Held
731K-
Black Rock Inc. New York, NY3.22MShares$9.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$6.73 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.06MShares$6.06 Million0.01% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny962KShares$2.83 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY613KShares$1.8 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $118M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...